Smoking cessation

Stephen I. Rennard, David M. Daughton

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

Cigarette smoking is a major preventable cause of morbidity and mortality. It is the major risk factor for chronic obstructive pulmonary disease in the developed world. Smoking is a chronic relapsing disease. Optimal treatment includes nonpharmacologic support, together with pharmacotherapy. All clinicians should be comfortable with the use of nicotine replacement therapy, bupropion, and varenicline. Second-line therapies can be used by those familiar with their use. Effective use of these medications requires their integration into an effective management plan, which is likely to be a long-term undertaking, involving several cycles of remission and relapse.

Original languageEnglish (US)
Pages (from-to)165-176
Number of pages12
JournalClinics in Chest Medicine
Volume35
Issue number1
DOIs
StatePublished - Mar 1 2014

Fingerprint

Smoking Cessation
Smoking
Bupropion
Nicotine
Chronic Obstructive Pulmonary Disease
Chronic Disease
Therapeutics
Morbidity
Recurrence
Drug Therapy
Mortality

Keywords

  • Cessation
  • Pharmacotherapy
  • Smoking
  • Treatment

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Rennard, S. I., & Daughton, D. M. (2014). Smoking cessation. Clinics in Chest Medicine, 35(1), 165-176. https://doi.org/10.1016/j.ccm.2013.11.002

Smoking cessation. / Rennard, Stephen I.; Daughton, David M.

In: Clinics in Chest Medicine, Vol. 35, No. 1, 01.03.2014, p. 165-176.

Research output: Contribution to journalReview article

Rennard, SI & Daughton, DM 2014, 'Smoking cessation', Clinics in Chest Medicine, vol. 35, no. 1, pp. 165-176. https://doi.org/10.1016/j.ccm.2013.11.002
Rennard, Stephen I. ; Daughton, David M. / Smoking cessation. In: Clinics in Chest Medicine. 2014 ; Vol. 35, No. 1. pp. 165-176.
@article{33af3837f5984fcba04fc9b3b1b798c7,
title = "Smoking cessation",
abstract = "Cigarette smoking is a major preventable cause of morbidity and mortality. It is the major risk factor for chronic obstructive pulmonary disease in the developed world. Smoking is a chronic relapsing disease. Optimal treatment includes nonpharmacologic support, together with pharmacotherapy. All clinicians should be comfortable with the use of nicotine replacement therapy, bupropion, and varenicline. Second-line therapies can be used by those familiar with their use. Effective use of these medications requires their integration into an effective management plan, which is likely to be a long-term undertaking, involving several cycles of remission and relapse.",
keywords = "Cessation, Pharmacotherapy, Smoking, Treatment",
author = "Rennard, {Stephen I.} and Daughton, {David M.}",
year = "2014",
month = "3",
day = "1",
doi = "10.1016/j.ccm.2013.11.002",
language = "English (US)",
volume = "35",
pages = "165--176",
journal = "Clinics in Chest Medicine",
issn = "0272-5231",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Smoking cessation

AU - Rennard, Stephen I.

AU - Daughton, David M.

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Cigarette smoking is a major preventable cause of morbidity and mortality. It is the major risk factor for chronic obstructive pulmonary disease in the developed world. Smoking is a chronic relapsing disease. Optimal treatment includes nonpharmacologic support, together with pharmacotherapy. All clinicians should be comfortable with the use of nicotine replacement therapy, bupropion, and varenicline. Second-line therapies can be used by those familiar with their use. Effective use of these medications requires their integration into an effective management plan, which is likely to be a long-term undertaking, involving several cycles of remission and relapse.

AB - Cigarette smoking is a major preventable cause of morbidity and mortality. It is the major risk factor for chronic obstructive pulmonary disease in the developed world. Smoking is a chronic relapsing disease. Optimal treatment includes nonpharmacologic support, together with pharmacotherapy. All clinicians should be comfortable with the use of nicotine replacement therapy, bupropion, and varenicline. Second-line therapies can be used by those familiar with their use. Effective use of these medications requires their integration into an effective management plan, which is likely to be a long-term undertaking, involving several cycles of remission and relapse.

KW - Cessation

KW - Pharmacotherapy

KW - Smoking

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84893431157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893431157&partnerID=8YFLogxK

U2 - 10.1016/j.ccm.2013.11.002

DO - 10.1016/j.ccm.2013.11.002

M3 - Review article

C2 - 24507844

AN - SCOPUS:84893431157

VL - 35

SP - 165

EP - 176

JO - Clinics in Chest Medicine

JF - Clinics in Chest Medicine

SN - 0272-5231

IS - 1

ER -